XML 16 R7.htm IDEA: XBRL DOCUMENT v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning of the period at Mar. 31, 2020 $ 1,489,268 $ (553) $ 30,148 $ 75,097 $ (185,896) $ 1,690,579 $ (553) $ (120,660)
Beginning of the period (in shares) at Mar. 31, 2020     173,106   6,210      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 739,253         721,510   17,743
Purchases of registered shares (72,725)       $ (72,725)      
Purchases of registered shares (in shares)         915      
Sales of shares upon exercise of stock options and purchase rights 29,709     (1,368) $ 31,077      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (1,461)      
Issuance of shares upon vesting of restricted stock units (29,475)     (48,968) $ 19,493      
Issuance of shares upon vesting of restricted stock units (in shares)         (1,031)      
Issuance of shares for contingent consideration 28,463     18,847 $ 9,616      
Issuance of shares for contingent consideration (in shares)         (390)      
Share-based compensation 64,532     64,532        
Cash dividends (146,705)         (146,705)    
End of the period at Dec. 31, 2020 2,101,767   $ 30,148 108,140 $ (198,435) 2,264,831   (102,917)
End of the period (in shares) at Dec. 31, 2020     173,106   4,243      
Beginning of the period at Sep. 30, 2020 1,705,963   $ 30,148 78,617 $ (166,258) 1,882,308   (118,852)
Beginning of the period (in shares) at Sep. 30, 2020     173,106   4,357      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 398,458         382,523   15,935
Purchases of registered shares (50,271)       $ (50,271)      
Purchases of registered shares (in shares)         603      
Sales of shares upon exercise of stock options and purchase rights 3,643     (2,733) $ 6,376      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (250)      
Issuance of shares upon vesting of restricted stock units (3,731)     (5,833) $ 2,102      
Issuance of shares upon vesting of restricted stock units (in shares)         (77)      
Issuance of shares for contingent consideration 28,463     18,847 $ 9,616      
Issuance of shares for contingent consideration (in shares)         (390)      
Share-based compensation 19,242     19,242        
End of the period at Dec. 31, 2020 2,101,767   $ 30,148 108,140 $ (198,435) 2,264,831   (102,917)
End of the period (in shares) at Dec. 31, 2020     173,106   4,243      
Beginning of the period at Mar. 31, 2021 2,261,789   $ 30,148 129,519 $ (279,541) 2,490,578   (108,915)
Beginning of the period (in shares) at Mar. 31, 2021     173,106   4,799      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 526,027         536,308   (10,281)
Purchases of registered shares (290,625)       $ (290,625)      
Purchases of registered shares (in shares)         3,035      
Sales of shares upon exercise of stock options and purchase rights 16,644     8,397 $ 8,247      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (226)      
Issuance of shares upon vesting of restricted stock units (58,528)     (93,967) $ 35,439      
Issuance of shares upon vesting of restricted stock units (in shares)         (969)      
Share-based compensation 72,045     72,045        
Cash dividends (159,410)         (159,410)    
End of the period at Dec. 31, 2021 2,367,942   $ 30,148 115,994 $ (526,480) 2,867,476   (119,196)
End of the period (in shares) at Dec. 31, 2021     173,106   6,639      
Beginning of the period at Sep. 30, 2021 2,262,683   $ 30,148 99,434 $ (413,345) 2,657,465   (111,019)
Beginning of the period (in shares) at Sep. 30, 2021     173,106   5,331      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 201,834         210,011   (8,177)
Purchases of registered shares (116,245)       $ (116,245)      
Purchases of registered shares (in shares)         1,379      
Sales of shares upon exercise of stock options and purchase rights 8     8        
Issuance of shares upon vesting of restricted stock units (3,777)     (6,887) $ 3,110      
Issuance of shares upon vesting of restricted stock units (in shares)         (71)      
Share-based compensation 23,439     23,439        
Cash dividends 0              
End of the period at Dec. 31, 2021 $ 2,367,942   $ 30,148 $ 115,994 $ (526,480) $ 2,867,476   $ (119,196)
End of the period (in shares) at Dec. 31, 2021     173,106   6,639